linkedin

Driven. For Life.

Here at Samsung Biologics, we believe that what we do today brings new hope and possibilities for tomorrow. Because we understand the dynamic nature of the healthcare industry and unpredictable nature of disease, we're driven to evolve for the needs of our partners and the patients they serve.

Through our innovation, passion, and unwavering dedication to find breakthrough solutions, we’re building a better, more sustainable future to improve the lives of millions around the world.

Our Vision

To enrich human life with
technology and innovation

Our Mission and
Innovation Strategy

By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for humanity through biomedicines.

3PInnovation

At Samsung Biologics, our innovation starts with the best People, specifically “Pi Type” people who are not only rooted in more than one field of expertise, but also with the ability to span their influence across the organization.

We invest in our People to develop Talent and demonstrate our core Values. We believe that attaining Knowledge builds Expertise, and combined with Creativity and strong Teamwork, we can achieve consistent Execution of our mission, all the while living our core values of Humanity, Integrity, Passion, Ownership and Dedication to each other, our clients, and to society.

Our People innovation is also the foundation upon which our other core innovation principles are built.

Process Innovation is how we ensure the highest quality by striving beyond “good” to “best” manufacturing practices through client-centric innovation. Our execution excellence is enhanced by our agility, adaptability, and speed in responding to changing global business conditions, resulting in cost competitiveness for the benefit of our clients and for patient access to life saving drugs.

Portfolio Innovation drives us to continuously expand our business scope and breadth of services beyond CMO to CDO and CRO, establishing global reach and proximity to our clients to offer fully integrated end-to-end services across an ever expanding diversified business portfolio, resulting in a highly maximized, “Super Value” for our shareholders and clients.

The ultimate purpose of our People, Process, and Portfolio Innovation is to support our Clients and become their most trusted partner in the mission to improving human lives through biomedicines.

We call this concept our “3P Innovation Chain” which is embedded in our business DNA – By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our Clients in achieving Better Life for humanity through biomedicines.

Choosing Samsung means choosing better. Better life-giving biologics for "Better Life."

Better Life with Samsung Biologics.

People

We invest in our people to develop talents and demonstrate our core values. We believe that attaining knowledge builds expertise, and combined with creativity and strong teamwork, we can achieve consistent execution of our mission, all the while living our core values of humanity, integrity, passion, ownership, and dedication to each other, our clients, and to society.

Talents
  • Knowledge
  • Expertise
  • Creativity
  • Teamwork
  • Execution
Values
  • Humanity
  • Integrity
  • Passion
  • Ownership
  • Dedication

Process

Process Innovation is how we ensure the highest quality by striving beyond “good” to “best” manufacturing practices through client-centric innovation. Our execution excellence is enhanced by our agility, adaptability, and speed in responding to changing global business conditions, resulting in cost competitiveness to the benefit of our clients and for patient access to life-saving drugs.

  • Highest Quality
  • Best Manufacturing Practices
  • Client-centric Innovation
  • Agility, Adaptability, Speed
  • Cost Competitiveness
  • Highest Quality
  • Best Manufacturing Practices
  • Client-centric Innovation
  • Agility, Adaptability, Speed
  • Cost Competitiveness

Portfolio

Portfolio Innovation drives us to continuously expand our business scope and breadth of services beyond CMO to CDO and bioanalytical testing, establishing global reach and proximity to our clients to offer fully integrated end-to-end services across an ever expanding diversified business portfolio, resulting in a highly maximized, “Super Value” for our shareholders and clients.

  • CMO, CDO, bioanalytical testing
  • Global Presence
  • Integrated Services
  • Business Diversification
  • Super Value for Shareholders
  • CMO, CDO, bioanalytical testing
  • Global Presence
  • Integrated Services
  • Business Diversification
  • Super Value for Shareholders

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved